While the same has not yet been validated through animal studies, there is reason to believe that niclosamide might have a beneficial effect in alleviating the symptoms that are presented by patients on the autism spectrum, especially because of its potentially negative impact on the ERK signaling pathway and its phosphorylation/activation. This evidence concerns the gene MAPK1 and autism.